Voluntary Counseling and Testing, Antiretroviral Therapy Access, and HIV-Related Stigma: Global Progress and Challenges

Abstract

To date, about 37 million people are living with the human immunodeficiency virus (HIV) and an estimated 680,000 people have died from acquired immune deficiency syndrome (AIDS) related illnesses globally. While all countries have been impacted by HIV, some have been significantly more impacted than others, particularly countries in sub-Saharan Africa. The purpose of this paper was to identify progress made in HIV prevention globally, particularly in the areas of voluntary counseling and testing (VCT) uptake, access to antiretroviral therapy (ART), and HIV-related stigma. With the development of ART, a cocktail of medications for the treatment of HIV, VCT uptake increased, as it became apparent that the medication would only be prescribed after an HIV diagnosis through testing. Widely considered a critical gateway to HIV prevention and treatment, VCT is being implemented in many countries, and as a result, about 38 million people living with HIV in 2018 had access to ART. Regardless of this success, major challenges still remain. We did an electronic search of 135 articles in English related to global HIV progress and challenges indexed in PubMed, ResearchGate, Google, and other search engines from 1998 to 2021. Sixty articles met the inclusion criteria for this paper. Data on trends in ART coverage were obtained from the Joint United Nations Programme on HIV/AIDS (UNAIDS) website. These data were used to show ART coverage globally in World Health Organization (WHO) regions. It was found that while global successes have been chalked in the areas of VCT uptake and ART coverage, HIV-related stigma has impeded greater success. This paper summarizes and discusses global successes and challenges in HIV prevention efforts in the past four decades with a focus on VCT, ART, and HIV-related stigma.

Mpox patients' experience from infection to treatment and implications for prevention and control: A multicenter qualitative study in China

“…Governments and media must ensure correct and comprehensive information is reported, avoiding the spread of misinformation, rumors. Effective public communication and community education should be used to eliminate misconceptions and normalize patients' social relationships 52,53 . Additionally, Families and peers are encouraged to provide companionship and be involved in mpox patients' access to vital psychological support.…”

HIV destigmatization: perspectives of people living with HIV in the Kumasi Metropolis in Ghana

“…It was in the bid to address the HIV epidemic that the global community launched the Millennium Development Goals (MDGs) in 2000, and the subsequent Sustainable Development Goals (SDGs) in 2015, with their respective targets of reversing HIV by 2015 (MDG 6) and eliminating HIV by 2030 (SDG 3) ( 8 , 9 ). Owing to these global efforts, public health interventions and campaigns, scientific advances, and technologies such as HIV testing, voluntary counselling and testing (VCT), and antiretroviral therapy (ART), have been developed and implemented across the globe to control and prevent HIV ( 10 ). In spite of these efforts, HIV prevention continues to be a global health issue, thanks to the stigma associated with the disease.…”

Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients

“…For three years, the world has been challenged by the coronavirus disease 2019 (COVID-19) pandemic, and a tremendous global effort has been made to tackle it. At the same time, we face other major health threats, such as infection with the human immunodeficiency virus (HIV), which is a disease affecting approximately 38 million people [ 1 , 2 ].…”